Suppr超能文献

采用多管齐下的方法来管理下游工艺中的β-葡聚糖污染物:通过电荷修饰的尼龙 6,6 膜过滤器控制原材料和过滤。

Multipronged approach to managing beta-glucan contaminants in the downstream process: control of raw materials and filtration with charge-modified nylon 6,6 membrane filters.

机构信息

Purification Process Development, Amgen Inc., Seattle, WA, USA.

出版信息

Biotechnol Prog. 2013 May-Jun;29(3):672-80. doi: 10.1002/btpr.1718. Epub 2013 Apr 18.

Abstract

(1→3)-β-D-Glucans (beta-glucans) have been found in raw materials used in the manufacture of recombinant therapeutics. Because of their biological activity, beta-glucans are considered process contaminants and consequently their level in the product needs to be controlled. Although beta-glucans introduced into the cell culture process can readily be removed by bind-and-elute chromatography process steps, beta-glucans can also be introduced into the purification process through raw materials containing beta-glucans as well as leachables from filters made from cellulose. This article reports a multipronged approach to managing the beta-glucan contamination in the downstream process. Raw material screening and selection can be used to effectively limit the level of beta-glucan introduced into the downstream process. Placement of a cellulosic filter upstream of the last bind-and-elute column step or effective preuse flushing can also limit the level of contaminant introduced. More importantly, this article reports the active removal of beta-glucan from the downstream process when necessary. It was discovered that the Posidyne(®) filter, a charge-modified nylon 6,6 membrane filter, was able to effectively remove beta-glucans from buffers at relatively low pH and salt concentrations. An approach of using low beta-glucan buffer components combined with filtration of the buffer with a Posidyne membrane has been successfully demonstrated at preparative scale. Additionally, the feasibility of active removal of beta-glucan from in-process product pools by Posidyne membrane filtration has also been demonstrated. Based on the data presented, a mechanism for binding is proposed, as well as a systematic approach for sizing of the Posidyne filter.

摘要

(1→3)-β-D-葡聚糖(β-葡聚糖)已在用于制造重组治疗药物的原材料中被发现。由于其生物活性,β-葡聚糖被视为过程污染物,因此需要控制其在产品中的水平。尽管在细胞培养过程中引入的β-葡聚糖可以通过结合-洗脱色谱过程步骤很容易地去除,但β-葡聚糖也可以通过含有β-葡聚糖的原材料以及由纤维素制成的过滤器的浸出物引入到纯化过程中。本文报告了一种多管齐下的方法来管理下游过程中的β-葡聚糖污染。原材料筛选和选择可有效限制引入下游过程的β-葡聚糖水平。在上游最后一个结合-洗脱柱步骤之前放置纤维素过滤器或有效的预冲洗也可以限制引入的污染物水平。更重要的是,本文报告了在必要时从下游过程中主动去除β-葡聚糖。发现 Posidyne(®)过滤器,一种带电荷修饰的尼龙 6,6 膜过滤器,能够在相对低的 pH 值和盐浓度下从缓冲液中有效去除β-葡聚糖。已经在中试规模成功证明了使用低β-葡聚糖缓冲成分结合 Posidyne 膜过滤缓冲液的方法。此外,还证明了通过 Posidyne 膜过滤从过程中产品池主动去除β-葡聚糖的可行性。基于呈现的数据,提出了一种结合机制,以及 Posidyne 过滤器的尺寸确定系统方法。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验